JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v10i5.15194ArticleGut Microbiota–Derived Metabolites of Dietary Polyphenols in Cognitive Aging: Bioavailability, Neuroinflammation, and Precision Nutrition Implicationshttps://artdesignp.com/journal/JCNR/10/5/10.26689/jcnr.v10i5.15194JiKeyu20261052026-05-31Cognitive aging, the age-related degeneration of cognitive ability, is an increasing global health issue, with diet becoming a variable to work on its course. Despite established neuroprotective properties of dietary polyphenols, most of the parent compounds have poor systemic bioavailability, prohibiting their direct action in the central nervous system (CNS). Recent studies have redirected interest to microbiota-derived catabolites; urolithins, equol, enterolignans, phenolic acids, and short-chain fatty acids (SCFAs) that are less toxic and can enter the systemic circulation and possibly cross the blood-brain barrier (BBB). This review identifies polyphenols-derived microbial metabolites as those that are generated by the gut rather than parent polyphenols. Cellular, animal, and limited human evidence implicates these metabolites in cellular neuroinflammation regulation and mitochondrial functioning in cognitive aging, albeit with varying strengths and limitations. Previous studies mainly focused on parent compounds even though most polyphenols reach the colon in their original form, where they are converted to bioactive metabolites with greater bioavailability by gut microbes. This has made these metabolites appear to be the major mediators of health benefits, and this emphasizes the need of microbial transformation processes. Nonetheless, there are still gaps, such as sparse clinical data and a high inter-individual disparity on metabolite production caused by microbiome disparities. The review also differentiates between cognitive aging, cognitive decline, and mild cognitive impairment (MCI) and marks the necessity of metabotype-based precision nutrition approaches.

An L, Lu Q, Wang K, et al., 2023, Urolithins: A Prospective Alternative Against Brain Aging. Nutrients, 15(18): 3884.

Zafari R, Goudarzi N, Kamroo A, et al., 2025, The Effects of Polyphenols on Gut Microbial Metabolites and Composition in Neurodegenerative Diseases: A Systematic Review. Nutrition & Metabolism, 22(1): 142.

Luo L, 2025, Promoting Cognitive Health Through the Nexus of Gut Microbiota and Dietary Phytochemicals. Frontiers in Nutrition, 12: 1636131.

Láng L, McArthur S, Lazar A, et al., 2024, Dietary (Poly)phenols and the Gut-Brain Axis in Ageing. Nutrients, 16(10): 1500.

Jarrín-Orozco M, Romo-Vaquero M, Carrascosa C, et al., 2025, Polyphenol-Related Gut Metabotype Signatures Linked to Quality of Life in Postmenopausal Women: A Randomized, Placebo-Controlled Crossover Trial. Nutrients, 17(22): 3572.

Liu S, Cheng L, Liu Y, et al., 2023, Relationship Between Dietary Polyphenols and Gut Microbiota: New Clues to Improve Cognitive Disorders, Mood Disorders and Circadian Rhythms. Foods, 12(6): 1309.

Zhang Q, Zhang W, Yuan X, et al., 2025, Urolithin A in Central Nervous System Disorders: Therapeutic Applications and Challenges. Biomedicines, 13(7): 1553.

Hong M, Cheng L, Liu Y, et al., 2022, Mechanisms Underlying the Interaction Between Chronic Neurological Disorders and Microbial Metabolites Via Tea Polyphenols Therapeutics. Frontiers in Microbiology, 13: 823902.

Mahdi L, Graziani A, Baffy G, et al., 2025, Unlocking Polyphenol Efficacy: The Role of Gut Microbiota in Modulating Bioavailability and Health Effects. Nutrients, 17(17): 2793.

Carecho R, Carregosa D, Santos C, 2020, Low Molecular Weight (Poly)phenol Metabolites Across the Blood-Brain Barrier: The Underexplored Journey. Brain Plasticity, 6(2): 193–214.

Singh A, D’Amico D, Andreux P, et al., 2021, Direct Supplementation with Urolithin A Overcomes Limitations of Dietary Exposure and Gut Microbiome Variability in Healthy Adults to Achieve Consistent Levels Across the Population. European Journal of Clinical Nutrition, 76(2): 297–308.

Wang W, Rangji C, Cairang N, et al., 2026, Urolithins: Promising Nutritional Interventions for Mild Cognitive Impairment. Journal of Functional Foods, 139: 107243.

Garay-Mayol B, Giménez-Bastida J, López-Cánovas D, et al., 2025, Urolithins and Their Phase II Conjugates Cross the Blood-Brain Barrier and Exert a Stimulus-Dependent Anti-Inflammatory Effect on Microglial Cells by Inhibiting NF-κB Nuclear Translocation. Food & Function, 16(23): 9006–9021.

Domínguez-López I, López-Yerena A, Vallverdú-Queralt A, et al., 2024, From the Gut to the Brain: The Long Journey of Phenolic Compounds with Neurocognitive Effects. Nutrition Reviews, 83(2): e533–e546.

Esselun C, Theyssen E, Eckert G, 2021, Effects of Urolithin A on Mitochondrial Parameters in a Cellular Model of Early Alzheimer Disease. International Journal of Molecular Sciences, 22(15): 8333.

Pamoda D, Hone E, Khaira H, et al., 2021, Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer's Disease. Nutrients, 13(11): 3744.

Chen P, Chen F, Lei J, et al., 2021, The Gut Microbiota Metabolite Urolithin B Improves Cognitive Deficits by Inhibiting Cyt C-Mediated Apoptosis and Promoting the Survival of Neurons Through the PI3K Pathway in Aging Mice. Frontiers in Pharmacology, 12: 768097.

Madsen H, Navarro C, Gasparini E, et al., 2024, Urolithin A and Nicotinamide Riboside Differentially Regulate Innate Immune Defenses and Metabolism in Human Microglial Cells. Frontiers in Aging Neuroscience, 16: 1503336.

Iglesias-Aguirre C, Cortés-Martín A, Ávila-Gálvez M, et al., 2021, Main Drivers of (Poly)phenol Effects on Human Health: Metabolite Production and/or Gut Microbiota-Associated Metabotypes? Food & Function, 12(21): 10324–10355.

Domínguez-López I, Parilli-Moser I, Vallverdú-Queralt A, et al., 2024, Microbial Phenolic Metabolites Are Associated with Better Frontal Lobe Cognition. Food Science and Human Wellness, 13(6): 3266–3272.

Rakhra G, Malhotra R, Prasad P, et al., 2026, Synergistic Effects of Polyphenols and Gut Microbiota-Derived Metabolites on Inflammation and Metabolic Syndrome: A Review. Molecular Nutrition & Food Research, 70(3): 70360.

Connell E, Gall G, Pontifex M, et al., 2022, Microbial-Derived Metabolites as a Risk Factor of Age-Related Cognitive Decline and Dementia. Molecular Neurodegeneration, 17(1): 43.

Ross F, Mayer D, Horn J, et al., 2024, Potential of Dietary Polyphenols for Protection from Age-Related Decline and Neurodegeneration: A Role for Gut Microbiota? Nutritional Neuroscience, 1–19.

Sarubbo F, Moranta D, Tejada S, et al., 2023, Impact of Gut Microbiota in Brain Ageing: Polyphenols as Beneficial Modulators. Antioxidants, 12(4): 812.

Makarov M, Korkotian E, 2023, Differential Role of Active Compounds in Mitophagy and Related Neurodegenerative Diseases. Toxins, 15(3): 202.

Asthana J, Shravage B, 2022, Exploring Therapeutic Potential of Mitophagy Modulators Using Drosophila Models of Parkinson's Disease. Frontiers in Aging Neuroscience, 14: 986849.

Libriani S, Facchinetti G, Marti F, et al., 2026, The Association Between Gut Microbiota and Cognitive Decline: A Systematic Review of the Literature. Nutrition Research, 147: 16–31.

Liu X, Alharbi A, Gibson R, et al., 2025, (Poly)phenol-Gut Microbiota Interactions and Their Impact on Human Health. Current Opinion in Clinical Nutrition & Metabolic Care, 28(4): 316–322.

Godos J, Micek A, Mena P, et al., 2023, Dietary (Poly)phenols and Cognitive Decline: A Systematic Review and Meta-Analysis of Observational Studies. Molecular Nutrition & Food Research, 68(1): e2300472.